171. ウィルソン病 ［臨床試験数：50，薬物数：59（DrugBank：17），標的遺伝子数：3，標的パスウェイ数：28］
Searched query = "Wilson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||EUCTR2014-001703-41-PL||22/12/2014||17/10/2014||A clinical trial in adult Wilson Disease Patients to evaluate efficacy and safety of WTX101 following administration for 24 weeks and an extension phase of 36 months.||A Phase 2, Multi-centre, Open-label, Study to Evaluate the Efficacy and Safety of WTX101 Administered for 24 Weeks in Newly Diagnosed Wilson Disease Patients Aged 18 and Older with an Extension Phase of 36 Months||Wilson Disease |
MedDRA version: 20.0Level: LLTClassification code 10047988Term: Wilson's diseaseSystem Organ Class: 100000004850;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
|Product Code: WTX101|
INN or Proposed INN: none
Other descriptive name: bis-choline TETRATHIOMOLYBDATE
|Wilson Therapeutics AB||NULL||Not Recruiting||Female: yes|
|30||Phase 2||United States;Poland;Austria;Germany;United Kingdom|